Vireo Growth Inc. ( VREOF) - Key Metrics
VREOF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $99,297.35 | -$0.02 | $0.02 | $0.01 |
| 2025Q3 | $0.10 | -$0.03 | -$0.01 | -$0.02 |
| 2025Q2 | $0.09 | -$0.03 | -$0.01 | -$0.02 |
| 2025Q1 | $0.07 | -$0.02 | -$0.01 | -$0.01 |
VREOF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -7.80 |
| 2025Q3 | ? | -5.78 |
| 2025Q2 | ? | -3.93 |
| 2025Q1 | ? | -6.48 |
VREOF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.00% | ? |
| 2025Q4 | 1.30% | ? |
| 2025Q3 | -3.49% | ? |
| 2025Q2 | -3.75% | ? |
| 2025Q1 | -2.65% | ? |
VREOF
Price: $12.58
52 week price:
Earnings Per Share: -0.16 USD
P/E Ratio: -2.60
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 481.1 million